- Home
- KMPR vs TMDX Comparison
KMPR vs TMDX Comparison
Compare KMPR & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMPR
- TMDX
- Stock Information
- Founded
- KMPR 1990
- TMDX 1998
- Country
- KMPR United States
- TMDX United States
- Employees
- KMPR N/A
- TMDX N/A
- Industry
- KMPR Property-Casualty Insurers
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KMPR Finance
- TMDX Health Care
- Exchange
- KMPR Nasdaq
- TMDX Nasdaq
- Market Cap
- KMPR 4.1B
- TMDX 4.7B
- IPO Year
- KMPR N/A
- TMDX 2019
- Fundamental
- Price
- KMPR $71.23
- TMDX $80.48
- Analyst Decision
- KMPR Strong Buy
- TMDX Buy
- Analyst Count
- KMPR 5
- TMDX 10
- Target Price
- KMPR $75.20
- TMDX $138.20
- AVG Volume (30 Days)
- KMPR 392.8K
- TMDX 2.3M
- Earning Date
- KMPR 10-30-2024
- TMDX 10-28-2024
- Dividend Yield
- KMPR 1.74%
- TMDX N/A
- EPS Growth
- KMPR N/A
- TMDX N/A
- EPS
- KMPR 4.20
- TMDX 0.94
- Revenue
- KMPR $4,639,300,000.00
- TMDX $401,090,000.00
- Revenue This Year
- KMPR N/A
- TMDX $83.25
- Revenue Next Year
- KMPR $12.54
- TMDX $26.27
- P/E Ratio
- KMPR $16.96
- TMDX $85.88
- Revenue Growth
- KMPR N/A
- TMDX 109.09
- 52 Week Low
- KMPR $40.93
- TMDX $66.76
- 52 Week High
- KMPR $71.57
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- KMPR 75.75
- TMDX 27.29
- Support Level
- KMPR $68.28
- TMDX $82.70
- Resistance Level
- KMPR $66.92
- TMDX $98.88
- Average True Range (ATR)
- KMPR 1.62
- TMDX 5.58
- MACD
- KMPR 0.69
- TMDX 1.01
- Stochastic Oscillator
- KMPR 96.73
- TMDX 3.06
About KMPR Kemper Corporation
Kemper Corp is a diversified insurance company that provides services in property and casualty insurance, along with life and health insurance. The company's property and casualty segment offers personal and commercial lines for home and automotive products. The company conducts its operations through two operating segments: Specialty Property & Casualty Insurance, and Life Insurance.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.